BRIEF-Erytech Pharma gets new patent in U.S. in asparaginase field

* Patent protects the process and methods detecting neutralizing factor activity of asparaginase in patients, including anti-asparaginase antibody
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.